Additionally, several cancer cells, such as non-small cell lung carcinoma and breast cancer, express high levels of PCK2, which controls mitochondrial PEP synthesis and tumor cell growth under low-glucose conditions 82–86. Here, PCK2 is linked to non-small cell lung carcinoma.